Artificial intelligence in healthcare is one of the clearest examples of technology meeting real‑world need, from spotting disease in scans to sorting hospital backlogs and supporting remote care. At a time when investors are tracking mixed global growth signals, shifting rate expectations and ongoing inflation debates, AI tools that promise better accuracy, lower costs and faster decisions stand out as a focused theme to research. This article walks through 3 stocks from our Transformative AI Healthcare Stocks screener, giving you a closer look at how they tie into this trend and how they can be considered within a diversified portfolio.
Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → watchlist · screener · Scan the sector by valuation on .
Overview: ASO International is a Japan based dental orthodontics company that designs and supplies a wide range of specialist devices and digital tools, from lingual and clear aligner systems to 3D printers, AI assisted scanning software and tele consultation services for dentists and patients.
Market Cap: ¥6.6b
For investors tracking AI in healthcare, ASO International brings together a long established orthodontics business with newer digital tools such as AI aided WE SCAN software and in house 3D printing services, which can appeal to clinics looking for more precise and efficient treatment workflows. The stock currently trades below some estimates of fair value, with earnings and revenue both forecast to grow, yet its recent share price performance has lagged the wider Japanese market. That disconnect, paired with double digit earnings growth forecasts, is what catches the eye, but there are real questions about governance, given the lack of independent directors and reliance on higher risk external borrowing that could matter if conditions tighten.
ASO International’s lagging share price compared with upbeat earnings forecasts hints at a story the market has not fully priced in yet. Check the to see what could be driving that gap.
TSE:9340 Earnings & Revenue Growth as at Jun 2026
Overview: eWeLLLtd runs a suite of cloud based tools that handle the paperwork and workflows behind home based medical and nursing care in Japan, from electronic medical records and insurance claims to attendance tracking, e learning and AI supported visit reports.
Market Cap: ¥28.1b
For investors focused on AI in healthcare, eWeLLLtd sits at the intersection of software and home care, with profit margins around 31.5% and return on equity above 30% that indicate an efficient business. At the same time, a P/E of 24.8x and share price performance that has lagged the wider market invite questions about what is already reflected in the valuation. Forecast revenue and earnings growth above 20% a year, together with an estimated value per share above the current price and ongoing buybacks plus a raised dividend outlook, make the investment case more substantial. However, the reliance on higher risk external borrowing and limited visibility on governance are important trade offs for you to weigh against the growth profile.
High margin growth with a 24.8x P/E and a share price that has lagged the wider market suggests investors might be missing part of eWeLLLtd’s story. The could reveal what the current valuation is really pricing in and where expectations might be stretched or surprisingly conservative.
TSE:5038 Earnings & Revenue Growth as at Jun 2026
Overview: FINDEX is a Japan based healthtech company that builds software and medical device systems for hospitals and clinics, covering everything from electronic medical records and imaging archives to AI supported medical text generation and workflow automation tools.
Market Cap: ¥20.4b
FINDEX stands out in the AI healthcare theme because it pairs a wide suite of hospital software and medical data tools with strong profitability metrics, including a 20.2% net margin and historically high returns on equity, while still trading on valuation multiples below the broader healthcare services industry. Forecast earnings growth of around 14.75% a year and revenue growth above the wider Japanese market keep the story grounded in fundamentals, and the company is returning cash through a steady dividend with a higher interim payout guided for 2026. The flip side is a balance sheet funded entirely by higher risk external borrowing and a board that has limited independence, which could matter more if growth slows or funding conditions change, and that is where the deeper questions start.
Strong profitability with lower valuation multiples can be a powerful mix, but FINDEX’s story is not that simple. Tap into the to see what might be hiding behind those numbers.
TSE:3649 Earnings & Revenue Growth as at Jun 2026
The three stocks in this article are just a starting point. The full has identified four more companies with equally compelling AI healthcare narratives that you have not seen yet. Use Simply Wall St to analyze and filter these stocks by the specific catalysts and narratives that matter to you, so you can identify the highest conviction ideas in this theme.
Take Control of Your Investment Journey
If ASO International or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Seeking Alternatives Before The Crowd Moves
Fresh stock ideas can move from quiet to flying once momentum builds, and early entries often vanish fast. Scan these curated lists while it matters and consider them promptly.
Spot income workhorses that aim to keep paying out while others stall by checking the for a focus on resilience and yield.
Look for early price strength in companies developing the next compute backbone by using the as a shortlist for potential breakout stories.
Search for potential mispricing in future facing miners with the curated , which focuses on producers connected to long term demand themes.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place We've created the ultimate portfolio companion for stock investors, and it's free. • Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Try a Demo Portfolio for Free
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
